Labcorp and Legacy Health Finalize Comprehensive Laboratory Relationship

Agreement Expands Access to Labcorp's Diagnostics Capabilities and Services BURLINGTON, N.C. , Nov. 20, 2023 /PRNewswire/ --  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of the previously announced transaction with Legacy

Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments

BURLINGTON, N.C. and WASHINGTON , Nov. 16, 2023 /PRNewswire/ -- Today, the Tigerlily Foundation   (Tigerlily), a leading breast cancer patient advocacy organization, and Labcorp , a global leader of innovative and comprehensive laboratory services, announced the launch of I AM INCLUDED , a

Ovia Health Unveils New Fertility and Family Building Benefit

Expanded offering adds inclusive end-to end support for pre-conception, adoption and surrogacy while removing barriers to equitable care access BOSTON , Nov. 8, 2023 /PRNewswire/ -- Ovia Health by Labcorp (Ovia) today announced it will offer a first-of-its-kind Fertility and Family Building Benefit

Labcorp Announces 2023 Third Quarter Results

Company Updates Full-Year Guidance Third quarter revenue grew 6.6% versus last year as the Base Business grew 14.0%.  Results from Continuing Operations for third quarter versus last year: Revenue: $3.06 billion versus $2.87 billion Diluted EPS: $2.11 versus $3.06 Adjusted EPS: $3.38 versus $4.01

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C. , Oct. 12, 2023 /PRNewswire/ --  Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 12, 2023

Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease

Test is available through physicians for use with patients being evaluated for possible Alzheimer's disease or other causes of cognitive impairment Labcorp is the first company to deliver a blood-based Amyloid-Tau-Neurodegeneration (ATN) Profile, which uses a trio of blood biomarkers to detect the

Colorectal cancer screening: Considerations when implementing your program

Colorectal cancer screening Considerations when implementing your programAccording to the American Cancer Society, colorectal cancer (CRC) is the third most common cancer diagnosed in the U.S. and the third leading cause of cancer-related deaths. Yet an estimated 60% of CRC deaths are preventable for those who follow colorectal cancer screening guidelines.

Labcorp and Baystate Health Announce Strategic Relationship for Diagnostic Laboratory Services

Labcorp to acquire Baystate Health's outreach laboratory business and select operating assets Collaboration to improve access and enhance affordable, high-quality healthcare services for underserved communities across Massachusetts BURLINGTON, N.C. , Oct.

Labcorp to Announce Third Quarter Financial Results on October 26, 2023

BURLINGTON, N.C. , Sept. 29, 2023 /PRNewswire/ -- Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2023 before the market opens on Thursday, October 26, 2023 .

Labcorp to Present Strategy, Business and Financial Outlook at Investor Day

BURLINGTON, N.C. , Sept. 14, 2023 /PRNewswire/ --  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting an Investor Day beginning at 1:00 p.m. ET today in New York City , expected to conclude by approximately 4:00 p.m. ET .